Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcadia Biosciences, Inc. - Common Stock (NQ:RKDA)

3.500 +0.040 (+1.16%)
Streaming Delayed Price Updated: 12:27 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,156
Open 3.500
Bid (Size) 3.400 (1)
Ask (Size) 3.540 (10)
Prev. Close 3.460
Today's Range 3.460 - 3.530
52wk Range 2.530 - 10.31
Shares Outstanding 950,406
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Arcadia Biosciences Sales Up 11 Percent
Via The Motley Fool
Topics Intellectual Property
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via GlobeNewswire

Performance

YTD
-42.5%
-42.5%
1 Month
-21.7%
-21.7%
3 Month
-29.7%
-29.7%
6 Month
+8.4%
+8.4%
1 Year
+21.1%
+21.1%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, BASE, RKDA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq – HLVX), Steelcase Inc. (NYSE – SCS), LAVA Therapeutics N.V. (Nasdaq – LVTX), Arcadia Biosciences, Inc. (Nasdaq – RKDA)
From Brodsky & Smith LLC
Via GlobeNewswire
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
Via Benzinga
What's Next: Arcadia Biosciences's Earnings Preview
Via Benzinga
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via GlobeNewswire
Earnings Scheduled For November 12, 2024
Via Benzinga
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
Earnings Scheduled For March 20, 2025
Via Benzinga
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire
RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDW, EBTC, RKDA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CDMO, RKDA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
ARCADIA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Arcadia Biosciences, Inc. - RKDA
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, RKDA, ENLC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Shareholder Alert: Ademi LLP investigates whether Arcadia Biosciences, Inc. is obtaining a Fair Price for its Public Shareholders
From Ademi LLP
Via Business Wire
Crude Oil Edges Lower; US Initial Jobless Claims Increase
Via Benzinga
Arcadia Biosciences Stock Are On The Rise Today: What's Going On?
Via Benzinga
RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Dow Falls 50 Points; Kroger Posts Downbeat Sales
Via Benzinga
Topics Stocks
Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights
From Arcadia Biosciences, Inc.
Via Business Wire
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call
From Arcadia Biosciences, Inc.
Via Business Wire

Frequently Asked Questions

Is Arcadia Biosciences, Inc. - Common Stock publicly traded?
Yes, Arcadia Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Arcadia Biosciences, Inc. - Common Stock trade on?
Arcadia Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Arcadia Biosciences, Inc. - Common Stock?
The ticker symbol for Arcadia Biosciences, Inc. - Common Stock is RKDA on the Nasdaq Stock Market
What is the current price of Arcadia Biosciences, Inc. - Common Stock?
The current price of Arcadia Biosciences, Inc. - Common Stock is 3.500
When was Arcadia Biosciences, Inc. - Common Stock last traded?
The last trade of Arcadia Biosciences, Inc. - Common Stock was at 09/16/25 12:27 PM ET
What is the market capitalization of Arcadia Biosciences, Inc. - Common Stock?
The market capitalization of Arcadia Biosciences, Inc. - Common Stock is 3.33M
How many shares of Arcadia Biosciences, Inc. - Common Stock are outstanding?
Arcadia Biosciences, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.